Investigation of COVID-19 associated neurological comorbidities

Investigation of COVID-19 associated neurological comorbidities - NEUROCOV-19

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023312

Enrollment

250

Registered

2020-10-13

Start date

2020-10-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurological comorbidity COVID-19 U07.1

Interventions

Group 1: Baseline patient characteristics will be recorded and include patient gender, age, ethnicity, presence of comorbidities, and admission data. Clinical data during the critical care course wil

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Confirmed Infection with COVID-19 age >= 18 years Signed Informed consent

Exclusion criteria

Exclusion criteria: No COVID-19 Infection

Design outcomes

Primary

Measure	Time frame
Registration of neurological comorbidity in COVID-19 patients	—

Secondary

Measure	Time frame
Analysis of the pathological mechanism of neurological comorbidity	—

Countries

Germany

Contacts

Public ContactMichael Fleischer

Universitätsklinikum Essen, Klinik für Neurologie

Michael.fleischer@uk-essen.de020172383181

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026